PROFOUND MED CORP's ticker is PROF and the CUSIP is 74319B502. A total of 33 filers reported holding PROFOUND MED CORP in Q1 2023. The put-call ratio across all filers is 0.06 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,099,000 | -21.4% | 401,833 | +0.3% | 0.00% | 0.0% |
| Q2 2023 | $5,213,000 | +39.9% | 400,680 | -0.1% | 0.00% | 0.0% |
| Q1 2023 | $3,725,000 | -14.4% | 400,994 | +0.3% | 0.00% | 0.0% |
| Q4 2022 | $4,352,000 | +178.6% | 399,620 | +3.4% | 0.00% | – |
| Q3 2022 | $1,562,000 | -44.6% | 386,620 | -0.1% | 0.00% | -100.0% |
| Q2 2022 | $2,821,000 | -2.6% | 387,006 | +20.3% | 0.00% | 0.0% |
| Q1 2022 | $2,896,000 | -1.5% | 321,701 | +22.9% | 0.00% | 0.0% |
| Q4 2021 | $2,939,000 | -20.6% | 261,703 | +3.5% | 0.00% | 0.0% |
| Q3 2021 | $3,701,000 | -10.2% | 252,776 | +0.3% | 0.00% | 0.0% |
| Q2 2021 | $4,121,000 | +3277.9% | 251,930 | +4043.6% | 0.00% | – |
| Q1 2021 | $122,000 | -28.7% | 6,080 | -26.9% | 0.00% | – |
| Q4 2020 | $171,000 | +66.0% | 8,314 | +41.9% | 0.00% | – |
| Q3 2020 | $103,000 | +10.8% | 5,861 | +6.7% | 0.00% | – |
| Q2 2020 | $93,000 | +116.3% | 5,495 | +26.2% | 0.00% | – |
| Q1 2020 | $43,000 | +7.5% | 4,354 | +17.7% | 0.00% | – |
| Q4 2019 | $40,000 | – | 3,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blackcrane Capital, LLC | 341,767 | $7,029,000 | 13.80% |
| GAGNON SECURITIES LLC | 821,196 | $16,883,000 | 2.69% |
| Gagnon Advisors, LLC | 277,252 | $5,700,000 | 2.56% |
| Taylor Wealth Management Partners | 166,294 | $3,419,000 | 1.32% |
| PCJ Investment Counsel Ltd. | 126,930 | $2,611,000 | 1.22% |
| EAM Global Investors LLC | 172,291 | $3,542,000 | 0.96% |
| AWM Investment Company, Inc. | 348,939 | $7,174,000 | 0.91% |
| PURA VIDA INVESTMENTS, LLC | 780,567 | $16,048,000 | 0.58% |
| Wealth Management Partners, LLC | 20,282 | $554,000 | 0.43% |
| Parkman Healthcare Partners LLC | 69,049 | $1,420,000 | 0.36% |